Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer.

Bioscience reports - 30 Oct 2020

Moazeni-Roodi Abdolkarim, Sarabandi Sahel, Karami Shima, Hashemi Mohammad, Ghavami Saeid

Abstract excerpt

Fibroblast growth factor receptor 4 (FGFR4) is a cell surface receptor tyrosine kinases (RTKs) for FGFs. Several studies have focused on the association between FGFR4 polymorphisms and cancer development. This meta-analysis aimed to estimate the association between FGFR4 rs351855 (Gly388Arg), rs1966265 (Val10Ile), rs7708357, rs2011077, and rs376618 polymorphisms and cancer risk. Eligible studies were identified...

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Genetic Association Studies
Share to Genetic Predisposition to Disease
Share to Neoplasms
Share to Polymorphism, Single Nucleotide
Share to Receptor, Fibroblast Growth Factor, Type 4
Share to Risk Assessment
Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 33017009
DOI: 10.1042/BSR20192051
PMCID: PMC7584815

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer.PMID 33017009Read ↗

Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.Semantic proximity Read ↗

FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects.Semantic proximity Read ↗

Association between fibroblast growth factor receptor-4 gene polymorphism and risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer.Semantic proximity Read ↗

New concept on association of FGFR4 G388R, V10I polymorphisms and risk of cancerSemantic proximity Read ↗

FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.Semantic proximity Read ↗

Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.Semantic proximity Read ↗

Variants of FGFR2 and their associations with breast cancer risk: a HUGE systematic review and meta-analysis.Semantic proximity Read ↗

Prognostic significance of fibroblast growth factor receptor 4 polymorphisms on biochemical recurrence after radical prostatectomy in a Chinese population.Semantic proximity Read ↗

Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis.Semantic proximity Read ↗

Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis.Semantic proximity Read ↗

Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.